Judith A. Coppinger

Dr. Judith A. Coppinger

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2004 in Blood
Verified
Journal Article
Closed access
PDF file
JCJudith A. Coppinger
Judith A. Coppinger
GCGerard Cagney
Gerard Cagney
STSinead Toomey
Sinead Toomey
TKThomas Kislinger
Thomas Kislinger
OBOrina Belton
Orina Belton
PMPatricia B Maguire
Patricia B Maguire
Proteins secreted by activated platelets can adhere to the vessel wall and promote the development of atherosclerosis and thrombosis. Despite this biologic significance, however, the complement of proteins comprising the platelet releasate is largely unknown. Using a proteomics approach, we have identified more than 300 proteins released by human platelets following thrombin activation. Many of the proteins identified were not previously attributed to platelets, including secretogranin III, a potential monocyte chemoattractant precursor; cyclophilin A, a vascular smooth muscle cell growth factor; calumenin, an inhibitor of the vitamin K epoxide reductase-warfarin interaction, as well as proteins of unknown function that map to expressed sequence tags. Secretogranin III, cyclophilin A, and calumenin were confirmed to localize in platelets and to be released upon activation. Furthermore, while absent in normal vasculature, they were identified in human atherosclerotic lesions. Therefore, these and other proteins released from platelets may contribute to atherosclerosis and to the thrombosis that complicates the disease. Moreover, as soluble extracellular proteins, they may prove suitable as novel therapeutic targets.

20 June 2008 in Science
Verified
Journal Article
Closed access
PDF file
ASAkiko Seki
Akiko Seki
JCJudith A. Coppinger
Judith A. Coppinger
CJChang-Young Jang
Chang-Young Jang
JYJohn R. Yates
John R. Yates
GFGuowei Fang
Guowei Fang
A central question in the study of cell proliferation is, what controls cell-cycle transitions? Although the accumulation of mitotic cyclins drives the transition from the G 2 phase to the M phase in embryonic cells, the trigger for mitotic entry in somatic cells remains unknown. We report that the synergistic action of Bora and the kinase Aurora A (Aur-A) controls the G 2 -M transition. Bora accumulates in the G 2 phase and promotes Aur-A–mediated activation of Polo-like kinase 1 (Plk1), leading to the activation of cyclin-dependent kinase 1 and mitotic entry. Mechanistically, Bora interacts with Plk1 and controls the accessibility of its activation loop for phosphorylation and activation by Aur-A. Thus, Bora and Aur-A control mitotic entry, which provides a mechanism for one of the most important yet ill-defined events in the cell cycle.

1 November 2006 in Cell
Verified
Journal Article
Closed access
XWXiaodong Wang
Xiaodong Wang
JVJohn Venable
John Venable
PLPaul LaPointe
Paul LaPointe
DHDarren M. Hutt
Darren M. Hutt
AKAtanas V. Koulov
Atanas V. Koulov
WBWilliam E. Balch
William E. Balch

1 February 2004 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
JMJ. P. McRedmond
J. P. McRedmond
SPS. D. Park
S. D. Park
DRD. F. Reilly
D. F. Reilly
JCJudith A. Coppinger
Judith A. Coppinger
PMPatricia B Maguire
Patricia B Maguire
DFD. J. Fitzgerald
D. J. Fitzgerald
Platelets, while anucleate, contain RNA, some of which is translated into protein upon activation. Hypothesising that the platelet proteome is reflected in the transcriptome, we identified 82 proteins secreted from activated platelets and compared these, as well as published proteomic data, to the transcriptional profile. We also compared the transcriptome of platelets to other tissues to identify platelet-specific genes and used ontology to determine gene categories over-represented in platelets. RNA was isolated from highly pure platelet preparations for hybridization to Affymetrix oligonucleotide arrays. We identified 2,928 distinct messages as being present in platelets. The platelet transcriptome was compared with the proteome by relating both to UniGene clusters. Platelet proteomic data correlated well with the transcriptome, with 69% of secreted proteins detectable at the mRNA level, and similar concordance was obtained using two published datasets. While many of the most abundant mRNAs are for known platelet proteins, messages were detected for proteins not previously reported in platelets. Some of these may represent residual megakaryocyte messages; however, proteomic analysis confirmed the expression of many previously unreported genes in platelets. Transcripts for well-described platelet proteins are among the most platelet-specific messages. Ontological categories related to signal transduction, receptors, ion channels, and membranes are over-represented in platelets, while categories involved in protein synthesis are depleted. Despite the absence of gene transcription, the platelet proteome is mirrored in the transcriptome. Conversely, transcriptional analysis predicts the presence of novel proteins in the platelet. Transcriptional analysis is relevant to platelet biology, providing insights into platelet function and the mechanisms of platelet disorders.

2 October 2014 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
WCWei-Chieh Chiang
Wei-Chieh Chiang
HKHeike Kroeger
Heike Kroeger
SSSanae Sakami
Sanae Sakami
CMCarissa Messah
Carissa Messah
DYDouglas Yasumura
Douglas Yasumura
JLJonathan Lin
Jonathan Lin

15 March 2010 in Molecular Biology of the Cell
Verified
Journal Article
Open access
AKAtanas V. Koulov
Atanas V. Koulov
PLPaul LaPointe
Paul LaPointe
BLBingwen Lu
Bingwen Lu
ARAbbas Razvi
Abbas Razvi
JCJudith A. Coppinger
Judith A. Coppinger
WBWilliam E. Balch
William E. Balch
The activator of Hsp90 ATPase 1, Aha1, has been shown to participate in the Hsp90 chaperone cycle by stimulating the low intrinsic ATPase activity of Hsp90. To elucidate the structural basis for ATPase stimulation of human Hsp90 by human Aha1, we have developed novel mass spectrometry approaches that demonstrate that the N- and C-terminal domains of Aha1 cooperatively bind across the dimer interface of Hsp90 to modulate the ATP hydrolysis cycle and client activity in vivo. Mutations in both the N- and C-terminal domains of Aha1 impair its ability to bind Hsp90 and stimulate its ATPase activity in vitro and impair in vivo the ability of the Hsp90 system to modulate the folding and trafficking of wild-type and variant (ΔF508) cystic fibrosis transmembrane conductance regulator (CFTR) responsible for the inherited disease cystic fibrosis (CF). We now propose a general model for the role of Aha1 in the Hsp90 ATPase cycle in proteostasis whereby Aha1 regulates the dwell time of Hsp90 with client. We suggest that Aha1 activity integrates chaperone function with client folding energetics by modulating ATPase sensitive N-terminal dimer structural transitions, thereby protecting transient folding intermediates in vivo that could contribute to protein misfolding systems disorders such as CF when destabilized.